Abstract
A survey of British consultant cardiologists was carried out to elicit their current practices when prescribing long term beta blockers after myocardial infarction. Sixty (72%) of the respondents reported that they used beta blockers prophylactically even in the absence of any other indications; the details of their stated policies, however, varied considerably. The favourable evidence of clinical trials in this indication appears to have been assimilated into hospital practice.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baber N. S., Lewis J. A. Confidence in results of beta-blocker postinfarction trials. Br Med J (Clin Res Ed) 1982 Jun 12;284(6331):1749–1750. doi: 10.1136/bmj.284.6331.1749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chamberlain D. A. Beta adrenoceptor antagonists after myocardial infarction--where are we now? Br Heart J. 1983 Feb;49(2):105–110. doi: 10.1136/hrt.49.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hampton J. R. The end of clinical freedom. Br Med J (Clin Res Ed) 1983 Oct 29;287(6401):1237–1238. doi: 10.1136/bmj.287.6401.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Staessen J., Bulpitt C., Cattaert A., Fagard R., Vanhees L., Amery A. Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients. Am Heart J. 1982 Dec;104(6):1395–1399. doi: 10.1016/0002-8703(82)90184-3. [DOI] [PubMed] [Google Scholar]